Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine versus magnesium sulfate as adjuvants in peribulbar block for posterior segment eye surgery
IRCT20210220050419N1Phase 2Completed
- Sponsor
- Research Institute of Ophthalmology
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ketamine and magnesium sulfate in posterior segment ophthalmic surgery (3 arms), sponsored by Research Institute of Ophthalmology. Primary endpoints: Onset of globe akinesia, Duration of globe akinesia and 7 more. Started Apr 2019; status: completed.
02
Drugs
ketaminemagnesium sulfate
03
Conditions
posterior segment ophthalmic surgery
Beyond the preview
Go deeper on IRCT20210220050419N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210220050419N1.